NCT02985216

Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain

A Randomized, Double-blind, Active-Controlled, Multi-center, Phase 3 Trial to Compare the Safety and Efficacy Between YHD1119 and Pregabalin in Patients With Peripheral Neuropathic Pain

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 371 (actual)
• Sponsor: Yuhan Corporation · Industry
• Sex: All
• Age: 19 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

A Randomized, Double-blind, Active-Controlled, Multi-center, Phase 3 Trial to Compare the Safety and Efficacy between YHD1119 and Pregabalin in Patients with Peripheral Neuropathic Pain

Conditions

• Peripheral Neuropathic Pain

Interventions

Type	Name	Description
DRUG	YHD1119	YHD1119 150mg, PO YHD1119 300mg, PO YHD1119 600mg, PO
DRUG	Lyrica	Lyrica 75mg, PO Lyrica 150mg, PO Lyrica 300mg, PO

Timeline

• Start date: 2017-02-07
• Primary completion: 2018-04-27
• Completion: 2018-05-02
• First posted: 2016-12-07
• Last updated: 2019-01-16

Locations

1 site across 1 country: South Korea